How should I evaluate and treat a patient with suspected scarring (cicatricial) alopecia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of Scarring (Cicatricial) Alopecia

For suspected scarring alopecia, perform an early scalp biopsy with multiple stains (H&E, PAS, Weigert) for definitive diagnosis, and initiate aggressive anti-inflammatory treatment immediately to prevent irreversible follicular destruction. 1

Clinical Assessment

Key clinical features to identify:

  • Assess for complete absence of follicular ostia (visible pore openings), which is the hallmark clinical sign distinguishing scarring from non-scarring alopecia 2
  • Document the time course of hair loss, presence of scalp symptoms (pain, burning, pruritus), signs of inflammation or infection, ease of hair pull-out, and any associated nail changes 1
  • Examine the entire body surface, not just the scalp, as systemic conditions like lupus erythematosus can cause scarring alopecia 1
  • Look for specific patterns: patchy hair loss with scalp inflammation, erythema, scaling, pustules, or follicular hyperkeratosis 3, 4

Trichoscopy (Dermoscopy)

Trichoscopy is essential as a non-invasive bedside tool that identifies specific patterns distinguishing between different scarring alopecia subtypes, guides optimal biopsy site selection, and provides photographic documentation to monitor treatment response objectively 1

  • Perform trichoscopy at every visit with photographic documentation to track disease progression or treatment response 1

Laboratory Workup

Order targeted laboratory tests to exclude secondary causes and assess for systemic involvement:

  • TSH to rule out thyroid disease, which can contribute to hair loss 1
  • Serum ferritin to assess for iron deficiency (target >60 ng/mL for optimal hair health) 1
  • Vitamin D and zinc levels as deficiencies may contribute to hair follicle dysfunction 1
  • Fungal culture when tinea capitis (which can cause secondary scarring) is suspected 1
  • Serology for lupus erythematosus when discoid lupus or systemic lupus is in the differential diagnosis 1
  • Serology for syphilis when secondary syphilis is suspected 1

Histopathologic Diagnosis

Skin biopsy is essential and should be performed early in the disease course before extensive scarring develops 1:

  • Obtain a 4mm punch biopsy from an area showing active inflammation (not from completely scarred areas) 1
  • Request multiple stains: hematoxylin and eosin (H&E), periodic acid-Schiff (PAS) to identify fungal elements, and Weigert stain to visualize elastic fibers and assess follicular destruction 1
  • A systematic histopathologic approach using multiple criteria allows accurate diagnosis in 92.3% of cases, even in late or pauci-inflammatory phases 1

Classification Based on Inflammatory Infiltrate

Primary scarring alopecias are classified by the predominant inflammatory cell type 3, 4, 5:

  • Lymphocytic: discoid lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia, central centrifugal alopecia, pseudopelade of Brocq 5
  • Neutrophilic: folliculitis decalvans, tufted folliculitis, dissecting cellulitis of the scalp 5
  • Mixed: folliculitis keloidalis 5

Treatment Approach

The primary goal is to stop or slow inflammatory waves and prevent further scarring—treatment cannot reverse established scarring 1, 6:

First-Line Anti-Inflammatory Treatment

  • Topical corticosteroids class III to IV applied to affected areas can be considered for most primary scarring alopecias 6
  • Intralesional triamcinolone acetonide injections into active inflammatory areas can be considered as first-line treatment 6

Systemic Therapy Selection

Choose systemic therapy based on the predominant inflammatory infiltrate identified on biopsy 6:

  • For lymphocytic scarring alopecias: immunomodulating or immunosuppressive agents 6
  • For neutrophilic scarring alopecias: antimicrobial or antibiotic agents 6

Monitoring and Support

  • Assess for signs of disease activity at each visit using clinical examination and trichoscopy with photographic comparison 1
  • Monitor for adverse effects of systemic treatments 1
  • Provide psychological support and discuss camouflage techniques, as scarring alopecia significantly impacts quality of life and psychological well-being 6

Critical Pitfalls to Avoid

  • Delayed diagnosis is common because hair loss can begin subclinically and progress slowly—maintain high clinical suspicion and biopsy early when scarring alopecia is suspected 6
  • Do not wait for extensive scarring before initiating treatment—early aggressive intervention is essential to prevent irreversible follicular destruction 1, 4
  • Do not expect hair regrowth in already scarred areas—set realistic expectations with patients that treatment aims to preserve remaining follicles, not restore lost hair 6
  • Do not rely solely on clinical appearance in subacute, early, or late disease stages—biopsy is necessary when diagnosis is uncertain 6

References

Guideline

Diagnosis and Management of Scarring Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Scarring alopecia].

Actas dermo-sifiliograficas, 2012

Research

Primary scarring alopecias.

Current problems in dermatology, 2015

Research

Cicatricial alopecia.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2018

Related Questions

What is cicatricial alopecia and how is it treated in a patient with a history of infected sebaceous cyst?
What is the best approach to diagnose and treat secondary scarring alopecia?
What is scarring alopecia (cicatricial alopecia)?
What is the classification of primary and secondary scarring (cicatricial) alopecia?
What is the difference between scarring alopecia and secondary scarring alopecia, particularly in patients with a history of autoimmune disorders?
What empiric antibiotic regimen should be used for an adult with pneumonia where Klebsiella pneumoniae is the likely pathogen, both in a healthy community‑acquired case and in patients with risk factors for MDR (multidrug‑resistant) strains?
What is the appropriate steroid regimen, including indications, dosing, duration, tapering, and monitoring, for a cystic fibrosis patient?
What is the recommended management for a patient who develops deep vein thrombosis after a prolonged airplane flight?
How should apixaban be dosed for a patient with a provoked deep‑vein thrombosis from long‑haul travel, including loading and maintenance doses, dose‑reduction criteria (age ≥ 80 years, weight ≤ 60 kg, impaired renal function), and alternatives if severe renal impairment or contraindications are present?
What are the diagnostic criteria and recommended management for diabetic ketoacidosis?
In a chronic kidney disease patient already on guideline‑directed statin and/or ezetimibe therapy, when should we assess lipoprotein(a) and how should an elevated level be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.